May 16, 2022
Abbott has reached an agreement with the U.S. Food and Drug Administration that paves the way for the company to reopen its infant formula plant in Michigan, which has been closed while regulators investigate potential links between Abbott's formula and a bacterial infection that made some babies sick earlier this year.